In addition to four known metabolites (4-acetyl-6,8-dihydroxy-5-methylisocoumarin, 6,8-dihydroxy-3-methylisocoumarin, 6,8-dihydroxy-3,5,7-trimethylisocoumarin and 3,3′-oxy-(5-methyl)-phenol), bioassay-guided fractionation of the culture of Keissleriella sp., a marine filamentous fungus (strain number: YS 4108), afforded an antifungal metabolite with a new carbon skeleton whose structure was elucidated spectrometrically as 3,6,8-trihydroxy-3-[3,5-dimethyl-2-oxo-3(E)-heptenyl]-2,3-dihydronaphthalen-1(4H)-one. In vitro antifungal assays of all isolates revealed that the new metabolite and 3,3′-oxybis[5-methylphenol] were inhibitory to the growth of the human pathogenic fungi Candida albicans, Tricophyton rubrum and Aspergillus niger with MICs of the former being 40, 20 and 80 μg/ml, and those of the latter 10, 30 and 50 μg/ml, respectively.
References
1
Fenical W.
Chemical studies of marine bacteria: developing a new resource.
Chem. Rev..
1993;
93
1673-83
4
Whyte A C, Gloer J B, Scott J A, Malloch D.
Cercophorins A-C: Novel antifungal and cytotoxic metabolites from coprophilous fungus Cercophora areolata
.
J. Nat. Prod..
1996;
59
765-9
5
Kendall J K, Fisher T H, Schultz H P, Schultz T P.
An improved synthesis of 6,8-dimethoxy-3-methylisocoumarin, a fungal metabolite precursor.
J. Org. Chem..
1989;
54
4218-20
7
Hornback J M, Poundstone M L, Vadlamani B, Graham S M, Gabay J, Patton S T.
Phytochemical cyclization of O-methylphenyl 1,3-diketones.
J. Org. Chem..
1988;
53
5597-601
9
Barchiesi F, Arzeni D, Fothergill A W, Di Francesco L F, Caselli F, Rinaldi M G, Scalise G.
In vitro activities of the new antifungal triazole SCH 56 592 against common and emerging yeast pathogens.
Antimicrob. Agents Chemother..
2000;
44
226-9
